Skip to main content
. 2021 Nov 4;13(11):1859. doi: 10.3390/pharmaceutics13111859

Table 2.

Endpoint titer of OVA-specific IgG1, IgG2a and IgG1/IgG2a ratio determined 21 days after immunization.

Group IgG1 IgG2a IgG1/IgG2a
OVA 1434 ± 360 14 ± 10 102
Al(OH)3/OVA 35,200 ± 13,000 58 ± 14 607
NPs/OVA 41,600 ± 15,648 358 ± 132 116